Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072631
Status:
COMPLETED
Last Update Posted:
2018-02-08
First Post:
2003-11-05
Brief Title:
Erlotinib Tarceva Trademark OSI-774 in Treating Patients With Advanced Non-Small Cell Lung Cancer
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2007-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2003-11-05
First Submit QC Date:
November 6 2003
Study First Post Date:
2003-11-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-06
Last Update Post Date:
2018-02-08
Last Update Post Date Type:
ACTUAL